Andrew Jonathan Balmer

Andrew Jonathan Balmer

Auto-generated profile, based on publicly available information

Andrew Jonathan Balmer

Wellcome Sanger Institute

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 October 2025 in eLife
Verified
Journal Article
Open access
ABAndrew J Balmer
Andrew J Balmer
NWNina Fd White
Nina Fd White
EÜEyyüb S Ünlü
Eyyüb S Ünlü
CLChiyun Lee
Chiyun Lee
RPRichard D Pearson
Richard D Pearson
CACristina Ariani
Cristina Ariani
Artemisinin partial resistance (ART-R) in Plasmodium falciparum is a major challenge to malaria control globally. Over the last two decades, ART-R has spread widely across Southeast Asia, undermining public health strategies and hindering elimination. As of 2024, ART-R has now emerged in East Africa, with the potential to dramatically impact current efforts to control malaria in the region. Mitigating its spread requires detailed genomic surveillance of point mutations in the kelch13 gene, the primary known determinant of artemisinin resistance. Although extensive surveillance data on these markers is available, it is distributed across many literature studies and open databases. In this review, we aggregate spatiotemporal data for 112,933 P. falciparum samples collected between 1980 and 2023 into a single resource, providing the most comprehensive overview of kelch13 markers to date. We outline the history and current status of these mutations globally, with particular focus on their emergence in Southeast Asia and East/Northeast Africa. Concerningly, we find the recent increases in ART-R in Africa mirror patterns observed in Southeast Asia 10–15 years ago. We examine factors that may influence its spread, including fitness costs, treatment strategies, and local epidemiological dynamics, before discussing potential scenarios for how resistance may spread in Africa in coming years. This review provides a comprehensive account of how the situation of ART-R has unfolded globally so far, highlighting insights for researchers and public health bodies which aim to reduce its negative effects.

18 July 2018 in Oikos
Verified
Journal Article
Open access
PDF file
ABAndrew J. Balmer
Andrew J. Balmer
PBPaul M. Brakefield
Paul M. Brakefield
OBOskar Brattström
Oskar Brattström
EBErik van Bergen
Erik van Bergen
Many organisms alter their investment in secondary sexual traits to optimise the fitness tradeoff between reproduction and survival. Though seasonal variation in the expression of sexual traits is evident (e.g. conspicuous breeding plumage in birds), little attention has been given to short‐lived organisms that inhabit relatively stable environments throughout their own lifetime but are exposed to strong environmental variation across generations. Some insects have evolved seasonal polyphenism to cope with intergenerational variation in environmental selection, yielding alternative phenotypes better suited for the environment in which they occur. Here we use mycalesine butterflies, which express distinct seasonal forms in response to wet‐dry seasonal environments, to explore whether seasonal polyphenism extends to secondary sexual traits. Sex pheromones, which are produced by androconial patches on the wings of males, are a key determinant of mating success in these species. Through a series of field sampling, reaction norm experiments, pheromone titre quantification, and mate competition experiments, this study reveals that the size of the androconial patch on the forewing is mediated by the temperatures experienced during development, which correspond to the ecological conditions during the alternative wet and dry seasons in the wild. Furthermore, in one of the species, Bicyclus anynana , larger forewing patches are associated with both an increase in the production of pheromone components as well as the likelihood of mating. Taken together, these findings indicate that plasticity in androconial patches may be an adaptation to seasonal fluctuations in the environment as it favours reproductive success in the conditions in which each seasonal form flies. We discuss our findings in the context of seasonal differences in the optimal tradeoff between reproduction and survival.

8 November 2021 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
GMGemma Murray
Gemma Murray
ABAndrew J. Balmer
Andrew J. Balmer
JHJosephine Herbert
Josephine Herbert
NHNazreen F. Hadjirin
Nazreen F. Hadjirin
CKCaroline L. Kemp
Caroline L. Kemp
LWLucy A. Weinert
Lucy A. Weinert
Mutation rates vary both within and between bacterial species, and understanding what drives this variation is essential for understanding the evolutionary dynamics of bacterial populations. In this study, we investigate two factors that are predicted to influence the mutation rate: ecology and genome size. We conducted mutation accumulation experiments on eight strains of the emerging zoonotic pathogen Streptococcus suis. Natural variation within this species allows us to compare tonsil carriage and invasive disease isolates, from both more and less pathogenic populations, with a wide range of genome sizes. We find that invasive disease isolates have repeatedly evolved mutation rates that are higher than those of closely related carriage isolates, regardless of variation in genome size. Independent of this variation in overall rate, we also observe a stronger bias towards G/C to A/T mutations in isolates from more pathogenic populations, whose genomes tend to be smaller and more AT-rich. Our results suggest that ecology is a stronger correlate of mutation rate than genome size over these timescales, and that transitions to invasive disease are consistently accompanied by rapid increases in mutation rate. These results shed light on the impact that ecology can have on the adaptive potential of bacterial pathogens.

24 August 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
ABAndrew Jonathan Balmer
Andrew Jonathan Balmer
NWNina F. D. White
Nina F. D. White
EÜEyyüb S. Ünlü
Eyyüb S. Ünlü
CLChiyun Lee
Chiyun Lee
RPRichard D. Pearson
Richard D. Pearson
CACristina V. Ariani
Cristina V. Ariani
Artemisinin partial resistance (ART-R) in Plasmodium falciparum is one of the most pressing threats to global malaria control. Over the last two decades, ART-R has spread widely across Southeast Asia, compromising public health strategies and hindering elimination efforts. As of 2024, ART-R has now emerged in East Africa, with the potential to dramatically increase human mortality in the region. Mitigating the spread of ART-R requires detailed genomic surveillance of point mutations in the kelch13 gene, the primary determinant of resistance to artemisinin derivatives. Although extensive surveillance data on these markers is available, it is distributed across many literature studies and open databases. In this literature review, we aggregate publicly available spatiotemporal data for 112,933 P. falciparum samples between 1980 – 2023 into a single resource, providing the most comprehensive overview of kelch13 markers to date. By synthesising insights from these samples over a global scale, we outline the history and current status of kelch13 mutations associated with ART-R, with particular reference to their emergence in Southeast Asia and recent emergence in East and Northeast Africa. Concerningly, we find their recent increases in frequency in these areas of Africa are comparable to those observed in Southeast Asia 10-15 years ago. We review several factors that may influence the spread of ART-R going forwards, such as fitness costs, treatment strategies, and local epidemiological dynamics, before articulating possible scenarios on how resistance may spread in Africa in coming years. In summary, this review provides a unified, comprehensive account of how the situation of ART-R has unfolded globally so far, highlighting insights both for researchers in the field and public health bodies which aim to reduce its negative effects. More broadly, we highlight the critical role genomic surveillance has had, and will continue to have in combating the spread of ART-R.

17 December 2025 in bioRxiv
Verified
Preprint
Open access
ABAndrew J. Balmer
Andrew J. Balmer
CLChiyun Lee
Chiyun Lee
RPRichard D. Pearson
Richard D. Pearson
CACristina V. Ariani
Cristina V. Ariani
JGJacob Almagro Garcia
Jacob Almagro Garcia
In the last decade, there has been substantial progress in vaccine development for malaria, with two WHO-recommended vaccines now available–RTS,S/AS01 (Mosquirix) and R21/Matrix-M. While these vaccines represent significant milestones, their partial efficacy underscores the need to develop next-generation vaccine approaches capable of broader, longer-lasting protection. Peptide vaccines are a promising strategy, as they focus on short, synthetic peptides specifically selected to trigger a T-cell immune response. However, developing effective peptide vaccines for malaria remains challenging, due to the extensive genetic diversity of Plasmodium falciparum. Currently, tools for comparing and prioritising immunogenic targets remain limited, and existing approaches overlook key factors, including genetic variation, lifecycle-stage expression, and peptide-level properties, each of which are critical for vaccine efficacy. To address these gaps, we developed Pf-PeptideFilter, an interactive web-based application and curated database designed for filtering peptide vaccine targets across the P. falciparum genome. By integrating population-scale genomic information (Pf7), liver-stage transcriptomics, and other biological annotations, Pf-PeptideFilter enables users to interactively filter potential vaccine candidates from the P. falciparum genome, based on several criteria relevant to vaccine design. The app allows users to prioritise candidate genes and peptides with immunogenic potential and export shortlists for incorporation into experimental workflows, offering an interactive platform for rational peptide vaccine design in P. falciparum . Author Summary: Malaria vaccines are challenging to design because the parasite responsible for most infections, Plasmodium falciparum , is highly genetically diverse. If a vaccine targets part of the parasite proteome that varies between strains, it may protect against only a subset of parasites and perform poorly across regions. Peptide vaccines offer a promising approach, by focusing immune responses on short, synthetic peptides selected to trigger T-cell immunity. However, identifying which peptides to include in a vaccine is difficult, as the parasite genome contains thousands of genes and huge numbers of potential peptide targets. Here, we introduce Pf-PeptideFilter, an interactive tool that helps researchers prioritise peptide vaccine candidates using a series of biologically relevant filters. We integrate population-scale genome variation from thousands of parasite samples with information on gene expression during liver infection, similarity to human proteins, and conservation across related parasite species. Users can adjust filtering thresholds and immediately see how these choices affect which genes and peptides are retained. Pf-PeptideFilter generates downloadable shortlists designed to support experimental follow-up, providing a robust and transparent platform for the early stages of vaccine design.

1 July 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
JBJaime Brizuela
Jaime Brizuela
GMGemma Murray
Gemma Murray
PBParichart Boueroy
Parichart Boueroy
ABAndrew J. Balmer
Andrew J. Balmer
TWThidathip Wongsurawat
Thidathip Wongsurawat
CSConstance Schultsz
Constance Schultsz
Background: Streptococcus suis is an emerging zoonotic porcine pathogen and a leading cause of adult bacterial meningitis in Southeast Asia, associated with raw pork consumption. Most zoonotic S. suis infections globally are by strains from lineage CC1 carrying a serotype 2 capsule. However, in Thailand, ∼40% of the reported zoonotic infections are caused by two endemic lineages, CC104 and CC233 which also have a serotype 2 capsule. In this study, we aimed to identify the drivers of the emergence and recent evolution of these two lineages. Methods: We sequenced the whole genomes of 141 Thai S. suis zoonotic and porcine strains isolated over a 15-year period and combined them with a curated global dataset of 2761 published S. suis genomes. Using comparative genomics, Bayesian evolutionary models and multivariate analysis we investigated the emergence of zoonotic potential and multi-drug resistance in CC104 and CC233. Findings: We estimated recent emergence dates for both CC104 (1990; 95% posterior: 1987-1992) and CC233 (2002; 95% posterior: 2000-2004). Both lineages acquired a serotype capsule 2 from CC1 through a capsule locus switching event, prior to their emergence. Both have also experienced multiple antimicrobial resistance (AMR) acquisition events, with some strains carrying 12 determinants encoding resistance against eight classes of antibiotics. Most importantly, CC104 and CC233 lineages are the first zoonotic lineages to have acquired increased resistance to penicillin and ceftriaxone, which form the standard therapy to treat S. suis infections in humans. Interpretation: Horizontal transfer of multiple genomic regions can cause rapid emergence of novel multi-drug-resistant zoonotic S. suis lineages. As S. suis is mainly controlled and treated through the use of antibiotics in both pigs and humans, these findings highlight the urgent need for improved and enhanced surveillance, infection control, and treatments.